CD4 and cancer: Similarly to CIBERSORT and xCell, EPIC and TIMER analyses both demonstrated that high-risk tumors harbor higher levels of CD4+ T cells, cancer-associated fibroblasts, neutrophils, dendritic cells, and macrophages, indicative of a more immune-suppressive microenvironment and tumor-promoting contexture.